Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy|Continue
JAMA Neurology
Sign In
Individual Sign In
Sign inCreate an Account
Access through your institution
Sign In
Purchase Options:
Subscribe to the JAMA Neurology journal
Editor's Choice: Tau-PET Prediction in MCI
Recurrent Ischemic Stroke in Patients With Atrial Fibrillation While Receiving Oral Anticoagulants
Mette Foldager Hindsholm, MD; Luis Alberto García Rodríguez, MD; Axel Brandes, PhD; et al
Original Investigation | June 24, 2024
online
June 24, 2024
Research
-
Recurrent Ischemic Stroke in Patients With Atrial Fibrillation While Receiving Oral Anticoagulants
Mette FoldagerHindsholm,MD; et al.
Original Investigation
Mette FoldagerHindsholm,MD; et al.
-
Sleep, 24-Hour Activity Rhythms, and Subsequent Amyloid-β Pathology
Phuong ThuyNguyen Ho,BSc; et al.
Original Investigation
See AlsoFor Authors | JAMA NeurologyJAMA Neurology - Impact Factor (IF), Overall Ranking, Rating, h-index, Call For Paper, Publisher, ISSN, Scientific Journal Ranking (SJR), Abbreviation, other Important DetailsJAMA Neurology Impact Factor And Other Key Metrics: Scite Analysis, H-Index, Citescore, SNIP, SJR, ISSN, Acceptance Rate & More | Editageopen access
Phuong ThuyNguyen Ho,BSc; et al.
-
Parental History of Memory Impairment and β-Amyloid
MabelSeto,PhD; et al.
Original Investigation
MabelSeto,PhD; et al.
Editorial
Opinion
-
Medical Forecasting—A Skill Set Worthy of Attention
Claire J.Creutzfeldt,MD; et al.
Viewpoint
Claire J.Creutzfeldt,MD; et al.
-
β-Amyloid in Cognitively Unimpaired Individuals
Dena B.Dubal,MD, PhD; et al.
Editorial
Dena B.Dubal,MD, PhD; et al.
-
Temperature Control After Cardiac Arrest
Daniel S.Harrison,MD; et al.
Viewpoint
Daniel S.Harrison,MD; et al.
Clinical Review & Education
-
Clinical Spectrum of Anti-GQ1b Antibody Syndrome
Sun-UkLee,MD, PhD; et al.
Review
has active quiz has multimedia
Sun-UkLee,MD, PhD; et al.
-
A 24-Year-Old Man With Spastic Ataxia and Hypodontia
LissaMarien,MD; et al.
JAMA Neurology Clinical Challenge
has active quiz
LissaMarien,MD; et al.
-
Progress in Pharmacologic Management of Neuropsychiatric Syndromes in Neurodegenerative Disorders
JeffreyCummings,MD, ScD(HC); et al.
Review
has active quiz
JeffreyCummings,MD, ScD(HC); et al.
Get the latest from JAMA Neurology
Sign Up
Privacy Policy | Terms of Use
Most Viewed(30 Days) RSS link
Most Cited(3 Years) RSS Link
-
9,835 Views
Immediate- or Delayed-Intensive Statin in Acute Cerebral Ischemia
-
8,456 Views
Tau-PET for Predicting Progression to Dementia in Individuals With MCI
-
6,221 Views
Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation
-
6,068 Views
Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology
-
3,806 Views
Sleep, 24-Hour Activity Rhythms, and Subsequent Amyloid-β Pathology
-
3,400 Views
Time Windows Between Symptom Onset and Treatment
-
3,271 Views
Brexpiprazole for the Treatment of Agitation in Alzheimer Dementia
-
3,009 Views
β-Amyloid in Cognitively Unimpaired Individuals
-
2,954 Views
Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease
-
2,706 Views
Association of Hearing Aids and Cochlear Implants With Cognitive Decline and Dementia
View more >
-
259 Citations
Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease
-
200 Citations
Differences Between Plasma and CSF GFAP Levels Across the Alzheimer Disease Continuum
-
191 Citations
Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease
-
137 Citations
Noncontrast CT vs CT Perfusion or MRI Selection in Late Presentation of Large-Vessel–Occlusion Stroke
-
134 Citations
Five-Year Extension Results of the Phase 1 START Trial
-
132 Citations
Accuracy of Tau PET as a Prognostic Marker
-
131 Citations
Global Prevalence of Young-Onset Dementia
-
130 Citations
Humoral and T-Cell Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Ocrelizumab
-
116 Citations
One-Year Trajectory of Cognition in Older COVID-19 Survivors
-
111 Citations
Comparison of Tau Species With Amyloid and Tau PET, Neurodegeneration, Vascular, and Cognitive Outcomes
View more >
X
.
Access your subscriptions
Add or change institution
Free access to newly published articles
To register for email alerts, access free PDF, and more
Purchase access
Get full journal access for 1 year
Get unlimited access and a printable PDF ($40.00)—
Sign in or create a free account
Access your subscriptions
Add or change institution
Free access to newly published articles
To register for email alerts, access free PDF, and more
Purchase access
Get full journal access for 1 year
Get unlimited access and a printable PDF ($40.00)—
Sign in or create a free account
Sign in to access free PDF
Add or change institution
Free access to newly published articles
To register for email alerts, access free PDF, and more
Save your search
Free access to newly published articles
To register for email alerts, access free PDF, and more
Purchase access
Customize your interests
Free access to newly published articles
To register for email alerts, access free PDF, and more
Create a personal account or sign in to:
- Register for email alerts with links to free full-text articles
- Access PDFs of free articles
- Manage your interests
- Save searches and receive search alerts
Privacy Policy
Make a comment
Free access to newly published articles
To register for email alerts, access free PDF, and more
Create a personal account or sign in to:
- Register for email alerts with links to free full-text articles
- Access PDFs of free articles
- Manage your interests
- Save searches and receive search alerts
Privacy Policy